Avidity Partners Management LP Viridian Therapeutics, Inc.\De Transaction History

Avidity Partners Management LP

  • $1.63 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$9.55 - $19.0 $9.93 Million - $19.8 Million
-1,040,000 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$16.79 - $20.88 $4 Million - $4.97 Million
-238,261 Reduced 18.64%
1,040,000 $19.2 Million
Q4 2021

Feb 14, 2022
BUY
$15.65 - $21.5 $20 Million - $27.5 Million
1,278,261 New
1,278,261 $25.3 Million

Others Institutions Holding VRDN

# of Institutions
178
Shares Held
76.6M
Call Options Held
581K
Put Options Held
439K
View Full List

About Viridian Therapeutics, Inc.\DE

VRDN Quotes by TradingView
  • Ticker VRDN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,888,900
  • Market Cap $765M
  • Description
  • Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...
More about VRDN
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email